Trial Profile
An Open-Label Study to Evaluate Pharmacokinetic Profile of Agile TCDS AG200-15 and to Compare Exposure to Ethinyl Estradiol to Oral Contraceptive (Orthocyclen®) in Healthy Female Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary) ; Ethinylestradiol/norgestimate
- Indications Pregnancy
- Focus Pharmacokinetics
- 29 Nov 2011 Results published in Contraception.
- 02 May 2011 Results presented at the 59th Annual Clinical Meeting of American College of Obstetricians and Gynecologists.
- 28 Nov 2010 New trial record